-
公开(公告)号:US11236112B2
公开(公告)日:2022-02-01
申请号:US16771977
申请日:2018-12-13
发明人: Lifang Wu , Huijun He , Jianyu Lu , Charles Z. Ding , Lihong Hu , Weidong Li , Shenyi Shi , Jian Li , Shuhui Chen
IPC分类号: C07D519/00 , A61P35/00 , A61K31/444 , A61K31/416 , A61K31/4439 , C07D487/04 , C07D471/04
摘要: Disclosed in the present invention are a crystal form and salt form of a TGF-βR1 inhibitor and a preparation method therefor, and further disclosed is an application of the crystal form and the salt form in preparation of medicines for treating cancers.